SCHEMBL8072335

SCHEMBL8072335

CC(=O)OC(CBr)CCCCCCCCCN1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.43
CYP1A2 P05177 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 3/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
MAOB P27338 5/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
RAD52 P43351 1/20 0.36
PAOX Q6QHF9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8076154 0.79 GAA (0.39) SMN1; SMN2KMT2A
SCHEMBL17965847 0.75 PRKCA (0.47)
SCHEMBL764405 0.71 PRKCA (0.42) ALDH1A1
SCHEMBL24628012 0.70 GAA (0.45) HRH3CYP1A2MAPK1SMN1; SMN2ALDH1A1
SCHEMBL8072046 0.69 HDAC1 (0.47) SMN1; SMN2MAOBKMT2A
SCHEMBL7296417 0.69 HRH3 (0.56) HRH3CYP1A2MAPK1SMN1; SMN2ALDH1A1
SCHEMBL7611212 0.69 TRPV1 (0.34)
SCHEMBL24627862 0.69 GAA (0.43) MAPK1ALDH1A1MAPT
SCHEMBL30964688 0.69 ALDH1A1 (0.43) HRH3CYP1A2MAPK1SMN1; SMN2ALDH1A1
SCHEMBL4922132 0.69 TSHR (0.39) CYP1A2SMN1; SMN2MAPTALOX15MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6121270-A N-(EPOXYALKYL)XANTHINE DERIVATIVES WHICH MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI CELL THERAPEUTICS, INC. (US) 2000-09-19 US disclosed
US-5866576-A COMPOUNDS THAT ACT AS DRUGS ON THE CELLULAR AND BIOCHEMICAL LEVEL TO MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI. CELL THERAPEUTICS, INC. (US) 1999-02-02 US disclosed